These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7968284

  • 1. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB, Rappaport DC, Ros PR, Torres GM.
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [Abstract] [Full Text] [Related]

  • 2. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR, Nicolas AI, Mergo PJ, Torres GM, Burton SS, Ros PR.
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [Abstract] [Full Text] [Related]

  • 3. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR, Steinman RM, Torres GM, Burton SS, Panaccione JL, Rappaport DC, McGorray SP.
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [Abstract] [Full Text] [Related]

  • 4. Enteric MRI contrast agents: comparative study of five potential agents in humans.
    Tart RP, Li KC, Storm BL, Rolfes RJ, Ang PG.
    Magn Reson Imaging; 1991 Oct; 9(4):559-68. PubMed ID: 1779727
    [Abstract] [Full Text] [Related]

  • 5. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN, Francis IR.
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [Abstract] [Full Text] [Related]

  • 6. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D, Gehl HB, Heuck A, Krahe T, Taupitz M, Lodemann KP, Hamm B.
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improved technique for pancreatic MRI: value of oblique fat suppression imaging with oral barium administration.
    Helmberger T, Mergo PJ, Stoupis C, Torres GM, Burton SS, Ros PR.
    J Comput Assist Tomogr; 1998 Jul; 22(3):391-7. PubMed ID: 9606379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC, Tart RP, Fitzsimmons JR, Storm BL, Mao J, Rolfes RJ.
    Magn Reson Imaging; 1991 Jul; 9(2):141-50. PubMed ID: 2034046
    [Abstract] [Full Text] [Related]

  • 11. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S, Uchida H, Yoshikawa K, Fujita N, Ohtomo K, Yuasa Y, Kawamura Y, Matsui O.
    Magn Reson Imaging; 1994 Jul; 12(6):837-46. PubMed ID: 7968283
    [Abstract] [Full Text] [Related]

  • 12. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen.
    Malcolm PN, Brown JJ, Hahn PF, Stillman AE, Li KC, Kawamura Y, Tanaka T, Noel JK, Molony BA, Johnson MF, Hildebolt CF.
    J Magn Reson Imaging; 2000 Nov; 12(5):702-7. PubMed ID: 11050639
    [Abstract] [Full Text] [Related]

  • 13. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL, Muller HH, Young SW.
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [Abstract] [Full Text] [Related]

  • 14. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media].
    Laniado M, Kaminsky S, Semmler W, Weinmann HJ, Zurth C, Claussen C.
    Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010
    [Abstract] [Full Text] [Related]

  • 15. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L, Tortora A, Maccioni F, Arpesani R, Marcelli G, Ascarelli A, Rossi P.
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [Abstract] [Full Text] [Related]

  • 16. Oral administration of a low-cost negative contrast agent: a three-year experience in routine practice.
    Ernst O, Sergent G, L'Hermine C.
    J Magn Reson Imaging; 1997 May; 7(3):495-8. PubMed ID: 9170033
    [Abstract] [Full Text] [Related]

  • 17. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T, Yoshikawa T, Saeki M, Nosaka S, Shimoyamada K, Nakajima Y, Ishikawa T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Two Neutral Oral Contrast Agents in Pediatric Patients: A Prospective Randomized Study.
    Dillman JR, Towbin AJ, Imbus R, Young J, Gates E, Trout AT.
    Radiology; 2018 Jul; 288(1):245-251. PubMed ID: 29737955
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics.
    Patten RM, Moss AA, Fenton TA, Elliott S.
    J Magn Reson Imaging; 1992 Jul; 2(1):25-34. PubMed ID: 1623278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.